2
Views
29
CrossRef citations to date
0
Altmetric
Original Article

Carcinoma of the Bladder: Cystectomy after Supervoltage Therapy

, &
Pages 215-221 | Received 01 Sep 1970, Published online: 09 Jul 2009
 

Abstract

For 10 years we have treated carcinoma of the bladder with external Cobalt 60 irradiation. In cases where the tumour was still viable 6 months after irradiation or showed a later recurrence, further treatment by cystectomy and urinary diversion is discussed. Out of 450 irradiated patients 35 were selected for complementary cystectomy and urinary diversion after irradiation. Six patients died of postoperative complications. Seven patients recovered uneventfully from surgery. The remainder had various severe complications. Fifteen patients died within 1 year of the operation. At follow-up, 9 patients are still living.

The pathologic anatomic specimens were graded according to malignancy of cell type and depth of growth. A significant correlation between histological grading and survival time was observed. Furthermore, a tendency towards short survival time was observed in cases where the tumour was penetrating the muscle.

The result of the present study have given us the impression that late surgery after irradiation of poorly differentiated tumours with growth in the muscle will not prolong the survival time and often will cause the patient unnecessary suffering.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.